In support of our findings, reduced GLP-1 secretion has been observed in CF patients75, leading to the proposition that decreased levels of GLP-1 secretion could affect the development of CF-related diabetes (CFRD)75, a condition primarily caused by insulin insufficiency2. This evidence concerns the gene INS and cystic fibrosis.